Uncategorized

Investors pour $115M into RQ Bio in search of a preventive flu drug

Published

on

The startup claims to have a “differentiated” antibody that can provide long-lasting protection against a variety of influenza strains.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version